{
  "ticker": "REGN",
  "year": 2024,
  "quarter": 2,
  "last_updated": "2025-04-19T08:46:13.654982",
  "count": 145,
  "transactions": [
    {
      "id": 64349,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-24",
      "transaction_shares": "14450",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "50887"
    },
    {
      "id": 64356,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-24",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 86307,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-24",
      "transaction_shares": "14450",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "50887"
    },
    {
      "id": 86315,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-24",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 110539,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-24",
      "transaction_shares": "14450",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "50887"
    },
    {
      "id": 110548,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-24",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 136693,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-24",
      "transaction_shares": "14450",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "50887"
    },
    {
      "id": 136702,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-24",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 164837,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-24",
      "transaction_shares": "14450",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "50887"
    },
    {
      "id": 164846,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-24",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 195441,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-24",
      "transaction_shares": "14450",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "50887"
    },
    {
      "id": 195450,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-24",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 64318,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-14",
      "transaction_shares": "1535",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "2917"
    },
    {
      "id": 86274,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-14",
      "transaction_shares": "1535",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "2917"
    },
    {
      "id": 110498,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-14",
      "transaction_shares": "1535",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "2917"
    },
    {
      "id": 136648,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-14",
      "transaction_shares": "1535",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "2917"
    },
    {
      "id": 164791,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-14",
      "transaction_shares": "1535",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "2917"
    },
    {
      "id": 195394,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-14",
      "transaction_shares": "1535",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "2917"
    },
    {
      "id": 64342,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-11",
      "transaction_shares": "7321",
      "transaction_price": "1015.28",
      "transaction_type": "S",
      "shares_after_transaction": "56877"
    },
    {
      "id": 86299,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-11",
      "transaction_shares": "7321",
      "transaction_price": "1015.28",
      "transaction_type": "S",
      "shares_after_transaction": "56877"
    },
    {
      "id": 110528,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-11",
      "transaction_shares": "7321",
      "transaction_price": "1015.28",
      "transaction_type": "S",
      "shares_after_transaction": "56877"
    },
    {
      "id": 136682,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-11",
      "transaction_shares": "7321",
      "transaction_price": "1015.28",
      "transaction_type": "S",
      "shares_after_transaction": "56877"
    },
    {
      "id": 164826,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-11",
      "transaction_shares": "7321",
      "transaction_price": "1015.28",
      "transaction_type": "S",
      "shares_after_transaction": "56877"
    },
    {
      "id": 195430,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-11",
      "transaction_shares": "7321",
      "transaction_price": "1015.28",
      "transaction_type": "S",
      "shares_after_transaction": "56877"
    },
    {
      "id": 64321,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "75799",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 64359,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-10",
      "transaction_shares": "1608",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 86277,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "75799",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 86318,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-10",
      "transaction_shares": "1608",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 110501,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "75799",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 110552,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-10",
      "transaction_shares": "1608",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 136651,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "75799",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 136706,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-10",
      "transaction_shares": "1608",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 164794,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "75799",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 164850,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-10",
      "transaction_shares": "1608",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 195397,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "75799",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 195455,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-10",
      "transaction_shares": "1608",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 64320,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-06",
      "transaction_shares": "787",
      "transaction_price": "1015.02",
      "transaction_type": "S",
      "shares_after_transaction": "64198"
    },
    {
      "id": 86276,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-06",
      "transaction_shares": "787",
      "transaction_price": "1015.02",
      "transaction_type": "S",
      "shares_after_transaction": "64198"
    },
    {
      "id": 110500,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-06",
      "transaction_shares": "787",
      "transaction_price": "1015.02",
      "transaction_type": "S",
      "shares_after_transaction": "64198"
    },
    {
      "id": 136650,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-06",
      "transaction_shares": "787",
      "transaction_price": "1015.02",
      "transaction_type": "S",
      "shares_after_transaction": "64198"
    },
    {
      "id": 164793,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-06",
      "transaction_shares": "787",
      "transaction_price": "1015.02",
      "transaction_type": "S",
      "shares_after_transaction": "64198"
    },
    {
      "id": 195396,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-06",
      "transaction_shares": "787",
      "transaction_price": "1015.02",
      "transaction_type": "S",
      "shares_after_transaction": "64198"
    },
    {
      "id": 64338,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-05",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 86295,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-05",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 110523,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-05",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 136676,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-05",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 164820,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-05",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 195424,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-05",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 64330,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-03",
      "transaction_shares": "2",
      "transaction_price": "979.4",
      "transaction_type": "S",
      "shares_after_transaction": "18080"
    },
    {
      "id": 64348,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-06-03",
      "transaction_shares": "1138",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14069"
    },
    {
      "id": 86287,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-03",
      "transaction_shares": "2",
      "transaction_price": "979.4",
      "transaction_type": "S",
      "shares_after_transaction": "18080"
    },
    {
      "id": 86306,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-06-03",
      "transaction_shares": "1138",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14069"
    },
    {
      "id": 110515,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-03",
      "transaction_shares": "2",
      "transaction_price": "979.4",
      "transaction_type": "S",
      "shares_after_transaction": "18080"
    },
    {
      "id": 110538,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-06-03",
      "transaction_shares": "1138",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14069"
    },
    {
      "id": 136667,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-03",
      "transaction_shares": "2",
      "transaction_price": "979.4",
      "transaction_type": "S",
      "shares_after_transaction": "18080"
    },
    {
      "id": 136692,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-06-03",
      "transaction_shares": "1138",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14069"
    },
    {
      "id": 164811,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-03",
      "transaction_shares": "2",
      "transaction_price": "979.4",
      "transaction_type": "S",
      "shares_after_transaction": "18080"
    },
    {
      "id": 164836,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-06-03",
      "transaction_shares": "1138",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14069"
    },
    {
      "id": 195415,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-03",
      "transaction_shares": "2",
      "transaction_price": "979.4",
      "transaction_type": "S",
      "shares_after_transaction": "18080"
    },
    {
      "id": 195440,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-06-03",
      "transaction_shares": "1138",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14069"
    },
    {
      "id": 64334,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-28",
      "transaction_shares": "1172",
      "transaction_price": "625.60",
      "transaction_type": "M",
      "shares_after_transaction": "2554"
    },
    {
      "id": 86291,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-28",
      "transaction_shares": "1172",
      "transaction_price": "625.60",
      "transaction_type": "M",
      "shares_after_transaction": "2554"
    },
    {
      "id": 110519,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-28",
      "transaction_shares": "1172",
      "transaction_price": "625.60",
      "transaction_type": "M",
      "shares_after_transaction": "2554"
    },
    {
      "id": 136672,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-28",
      "transaction_shares": "1172",
      "transaction_price": "625.60",
      "transaction_type": "M",
      "shares_after_transaction": "2554"
    },
    {
      "id": 164816,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-28",
      "transaction_shares": "1172",
      "transaction_price": "625.60",
      "transaction_type": "M",
      "shares_after_transaction": "2554"
    },
    {
      "id": 195420,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-28",
      "transaction_shares": "1172",
      "transaction_price": "625.60",
      "transaction_type": "M",
      "shares_after_transaction": "2554"
    },
    {
      "id": 44627,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-05-21",
      "transaction_shares": "1865",
      "transaction_price": "994.9",
      "transaction_type": "S",
      "shares_after_transaction": "34678"
    },
    {
      "id": 64344,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-05-21",
      "transaction_shares": "1865",
      "transaction_price": "994.9",
      "transaction_type": "S",
      "shares_after_transaction": "34678"
    },
    {
      "id": 86301,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-05-21",
      "transaction_shares": "1865",
      "transaction_price": "994.9",
      "transaction_type": "S",
      "shares_after_transaction": "34678"
    },
    {
      "id": 110532,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-05-21",
      "transaction_shares": "1865",
      "transaction_price": "994.9",
      "transaction_type": "S",
      "shares_after_transaction": "34678"
    },
    {
      "id": 136686,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-05-21",
      "transaction_shares": "1865",
      "transaction_price": "994.9",
      "transaction_type": "S",
      "shares_after_transaction": "34678"
    },
    {
      "id": 164830,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-05-21",
      "transaction_shares": "1865",
      "transaction_price": "994.9",
      "transaction_type": "S",
      "shares_after_transaction": "34678"
    },
    {
      "id": 195434,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-05-21",
      "transaction_shares": "1865",
      "transaction_price": "994.9",
      "transaction_type": "S",
      "shares_after_transaction": "34678"
    },
    {
      "id": 44632,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-17",
      "transaction_shares": "22687",
      "transaction_price": "979.22",
      "transaction_type": "S",
      "shares_after_transaction": "467020"
    },
    {
      "id": 64351,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-17",
      "transaction_shares": "22687",
      "transaction_price": "979.22",
      "transaction_type": "S",
      "shares_after_transaction": "467020"
    },
    {
      "id": 86310,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-17",
      "transaction_shares": "22687",
      "transaction_price": "979.22",
      "transaction_type": "S",
      "shares_after_transaction": "467020"
    },
    {
      "id": 110543,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-17",
      "transaction_shares": "22687",
      "transaction_price": "979.22",
      "transaction_type": "S",
      "shares_after_transaction": "467020"
    },
    {
      "id": 136697,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-17",
      "transaction_shares": "22687",
      "transaction_price": "979.22",
      "transaction_type": "S",
      "shares_after_transaction": "467020"
    },
    {
      "id": 164841,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-17",
      "transaction_shares": "22687",
      "transaction_price": "979.22",
      "transaction_type": "S",
      "shares_after_transaction": "467020"
    },
    {
      "id": 195445,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-17",
      "transaction_shares": "22687",
      "transaction_price": "979.22",
      "transaction_type": "S",
      "shares_after_transaction": "467020"
    },
    {
      "id": 44615,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-16",
      "transaction_shares": "907",
      "transaction_price": "967.4",
      "transaction_type": "S",
      "shares_after_transaction": "835476"
    },
    {
      "id": 64328,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-16",
      "transaction_shares": "907",
      "transaction_price": "967.4",
      "transaction_type": "S",
      "shares_after_transaction": "835476"
    },
    {
      "id": 86285,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-16",
      "transaction_shares": "907",
      "transaction_price": "967.4",
      "transaction_type": "S",
      "shares_after_transaction": "835476"
    },
    {
      "id": 110513,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-16",
      "transaction_shares": "907",
      "transaction_price": "967.4",
      "transaction_type": "S",
      "shares_after_transaction": "835476"
    },
    {
      "id": 136665,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-16",
      "transaction_shares": "907",
      "transaction_price": "967.4",
      "transaction_type": "S",
      "shares_after_transaction": "835476"
    },
    {
      "id": 164809,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-16",
      "transaction_shares": "907",
      "transaction_price": "967.4",
      "transaction_type": "S",
      "shares_after_transaction": "835476"
    },
    {
      "id": 195413,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-16",
      "transaction_shares": "907",
      "transaction_price": "967.4",
      "transaction_type": "S",
      "shares_after_transaction": "835476"
    },
    {
      "id": 44611,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "111",
      "transaction_price": "965.69",
      "transaction_type": "S",
      "shares_after_transaction": "886272"
    },
    {
      "id": 64324,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "111",
      "transaction_price": "965.69",
      "transaction_type": "S",
      "shares_after_transaction": "886272"
    },
    {
      "id": 86281,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "111",
      "transaction_price": "965.69",
      "transaction_type": "S",
      "shares_after_transaction": "886272"
    },
    {
      "id": 110507,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "111",
      "transaction_price": "965.69",
      "transaction_type": "S",
      "shares_after_transaction": "886272"
    },
    {
      "id": 136657,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "111",
      "transaction_price": "965.69",
      "transaction_type": "S",
      "shares_after_transaction": "886272"
    },
    {
      "id": 164801,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "111",
      "transaction_price": "965.69",
      "transaction_type": "S",
      "shares_after_transaction": "886272"
    },
    {
      "id": 195405,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "111",
      "transaction_price": "965.69",
      "transaction_type": "S",
      "shares_after_transaction": "886272"
    },
    {
      "id": 44636,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-13",
      "transaction_shares": "203204",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "577633"
    },
    {
      "id": 64355,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-13",
      "transaction_shares": "203204",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "577633"
    },
    {
      "id": 86314,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-13",
      "transaction_shares": "203204",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "577633"
    },
    {
      "id": 110547,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-13",
      "transaction_shares": "203204",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "577633"
    },
    {
      "id": 136701,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-13",
      "transaction_shares": "203204",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "577633"
    },
    {
      "id": 164845,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-13",
      "transaction_shares": "203204",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "577633"
    },
    {
      "id": 195449,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-13",
      "transaction_shares": "203204",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "577633"
    },
    {
      "id": 44609,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "2000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "28349"
    },
    {
      "id": 64322,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "2000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "28349"
    },
    {
      "id": 86278,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "2000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "28349"
    },
    {
      "id": 110502,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "2000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "28349"
    },
    {
      "id": 136652,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "2000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "28349"
    },
    {
      "id": 164795,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "2000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "28349"
    },
    {
      "id": 195398,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "2000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "28349"
    },
    {
      "id": 44631,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-05-01",
      "transaction_shares": "250",
      "transaction_price": "889.41",
      "transaction_type": "S",
      "shares_after_transaction": "12931"
    },
    {
      "id": 44635,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "3",
      "transaction_price": "889.5",
      "transaction_type": "S",
      "shares_after_transaction": "18179"
    },
    {
      "id": 64350,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-05-01",
      "transaction_shares": "250",
      "transaction_price": "889.41",
      "transaction_type": "S",
      "shares_after_transaction": "12931"
    },
    {
      "id": 64354,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "3",
      "transaction_price": "889.5",
      "transaction_type": "S",
      "shares_after_transaction": "18179"
    },
    {
      "id": 86308,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-05-01",
      "transaction_shares": "250",
      "transaction_price": "889.41",
      "transaction_type": "S",
      "shares_after_transaction": "12931"
    },
    {
      "id": 86313,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "3",
      "transaction_price": "889.5",
      "transaction_type": "S",
      "shares_after_transaction": "18179"
    },
    {
      "id": 110540,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-05-01",
      "transaction_shares": "250",
      "transaction_price": "889.41",
      "transaction_type": "S",
      "shares_after_transaction": "12931"
    },
    {
      "id": 110546,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "3",
      "transaction_price": "889.5",
      "transaction_type": "S",
      "shares_after_transaction": "18179"
    },
    {
      "id": 136694,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-05-01",
      "transaction_shares": "250",
      "transaction_price": "889.41",
      "transaction_type": "S",
      "shares_after_transaction": "12931"
    },
    {
      "id": 136700,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "3",
      "transaction_price": "889.5",
      "transaction_type": "S",
      "shares_after_transaction": "18179"
    },
    {
      "id": 164838,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-05-01",
      "transaction_shares": "250",
      "transaction_price": "889.41",
      "transaction_type": "S",
      "shares_after_transaction": "12931"
    },
    {
      "id": 164844,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "3",
      "transaction_price": "889.5",
      "transaction_type": "S",
      "shares_after_transaction": "18179"
    },
    {
      "id": 195442,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-05-01",
      "transaction_shares": "250",
      "transaction_price": "889.41",
      "transaction_type": "S",
      "shares_after_transaction": "12931"
    },
    {
      "id": 195448,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "3",
      "transaction_price": "889.5",
      "transaction_type": "S",
      "shares_after_transaction": "18179"
    },
    {
      "id": 44628,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-04-29",
      "transaction_shares": "36296",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 64345,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-04-29",
      "transaction_shares": "36296",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 86302,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-04-29",
      "transaction_shares": "36296",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 110534,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-04-29",
      "transaction_shares": "36296",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 136688,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-04-29",
      "transaction_shares": "36296",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 164832,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-04-29",
      "transaction_shares": "36296",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 195436,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-04-29",
      "transaction_shares": "36296",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 27642,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 27658,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    },
    {
      "id": 44613,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 44634,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    },
    {
      "id": 64326,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 64353,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    },
    {
      "id": 86283,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 86312,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    },
    {
      "id": 110511,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 110545,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    },
    {
      "id": 136661,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 136699,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    },
    {
      "id": 164805,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 164843,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    },
    {
      "id": 195409,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 195447,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    }
  ]
}